In another study, we observed higher numbers of intratumoral IL-17-producing cells in HCC patients who underwent TACE before surgical resection compared to those who did not receive any treatment prior to surgery (unpublished results). This evidence concerns the gene IL17A and hepatocellular carcinoma.